Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.53 USD | -4.67% |
|
+7.85% | -23.78% |
Jul. 01 | Korro Bio Joins Russell 2000, 3000, Microcap Indexes | MT |
Jul. 01 | Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell Small Cap Comp Value Index | CI |
Valuation
Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Capitalization 1 | 383.3 | 338.7 | - | - |
Enterprise Value (EV) 1 | 383.3 | 338.7 | 338.7 | 338.7 |
P/E ratio | -0.9 x | -3.79 x | -3.87 x | -4.43 x |
Yield | - | - | - | - |
Capitalization / Revenue | - | - | - | - |
EV / Revenue | - | - | - | - |
EV / EBITDA | - | - | - | - |
EV / FCF | -5.1 x | -4.08 x | -3.68 x | - |
FCF Yield | -19.6% | -24.5% | -27.2% | - |
Price to Book | - | - | - | - |
Nbr of stocks (in thousands) | 7,997 | 9,273 | - | - |
Reference price 2 | 47.93 | 36.53 | 36.53 | 36.53 |
Announcement Date | 3/26/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - |
EBITDA | - | - | - | - | - |
EBIT 1 | - | -84.53 | -86.3 | -95.42 | -101.8 |
Operating Margin | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -58.02 | -81.14 | -81.12 | -92.65 | -101.8 |
Net income 1 | -58.03 | -81.17 | -81.16 | -92.65 | -101.8 |
Net margin | - | - | - | - | - |
EPS 2 | - | -53.08 | -9.640 | -9.437 | -8.250 |
Free Cash Flow 1 | - | -75.12 | -83 | -92 | - |
FCF margin | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 7/27/23 | 3/26/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | -26.89 | -21.45 | -20.91 | -21.28 | -21.91 | -22.5 | -23.12 |
Operating Margin | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -25.4 | -19.54 | -20.33 | -20.51 | -21.22 | -21.88 | -22.6 |
Net income 1 | -25.43 | -19.56 | -20.34 | -20.51 | -21.22 | -21.88 | -22.6 |
Net margin | - | - | - | - | - | - | - |
EPS 2 | -43.10 | -2.440 | -2.395 | -2.340 | -2.465 | -2.600 | -2.480 |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 3/26/24 | 5/14/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow 1 | - | -75.1 | -83 | -92 | - |
ROE (net income / shareholders' equity) | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex 1 | - | 7.84 | 5 | 5 | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 7/27/23 | 3/26/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.78% | 339M | |
+18.97% | 45.34B | |
+42.21% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- KRRO Stock
- Financials Korro Bio, Inc.